BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11238058)

  • 1. Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.
    Zareie M; Singh PK; Irvine EJ; Sherman PM; McKay DM; Perdue MH
    Am J Pathol; 2001 Mar; 158(3):1101-9. PubMed ID: 11238058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2.
    McKay DM; Singh PK
    J Immunol; 1997 Sep; 159(5):2382-90. PubMed ID: 9278329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4.
    Lu J; Philpott DJ; Saunders PR; Perdue MH; Yang PC; McKay DM
    J Pharmacol Exp Ther; 1998 Oct; 287(1):128-36. PubMed ID: 9765331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.
    Söderholm JD; Streutker C; Yang PC; Paterson C; Singh PK; McKay DM; Sherman PM; Croitoru K; Perdue MH
    Gut; 2004 Dec; 53(12):1817-24. PubMed ID: 15542521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved effects of novel glucocorticosteroids on immune-induced epithelial pathophysiology.
    Zareie M; Brattsand R; Sherman PM; McKay DM; Perdue MH
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1245-9. PubMed ID: 10336512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease.
    Keita AV; Salim SY; Jiang T; Yang PC; Franzén L; Söderkvist P; Magnusson KE; Söderholm JD
    J Pathol; 2008 Jun; 215(2):135-44. PubMed ID: 18348161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiflagellin antibodies recognize the autoantigens Toll-Like Receptor 5 and Pals 1-associated tight junction protein and induce monocytes activation and increased intestinal permeability in Crohn's disease.
    Lunardi C; Bason C; Dolcino M; Navone R; Simone R; Saverino D; Frulloni L; Tinazzi E; Peterlana D; Corrocher R; Puccetti A
    J Intern Med; 2009 Feb; 265(2):250-65. PubMed ID: 18796002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor-alpha production stimulated by heat shock protein 70 and its inhibition in circulating dendritic cells and cells eluted from mucosal tissues in Crohn's disease.
    Whittall T; Wang Y; Kelly CG; Thompson R; Sanderson J; Lomer M; Soon SY; Bergmeier LA; Singh M; Lehner T
    Clin Exp Immunol; 2006 Mar; 143(3):550-9. PubMed ID: 16487255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte/macrophages evoke epithelial dysfunction: indirect role of tumor necrosis factor-alpha.
    Zareie M; McKay DM; Kovarik GG; Perdue MH
    Am J Physiol; 1998 Oct; 275(4):C932-9. PubMed ID: 9755046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
    Suenaert P; Bulteel V; Lemmens L; Noman M; Geypens B; Van Assche G; Geboes K; Ceuppens JL; Rutgeerts P
    Am J Gastroenterol; 2002 Aug; 97(8):2000-4. PubMed ID: 12190167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
    Zeissig S; Bojarski C; Buergel N; Mankertz J; Zeitz M; Fromm M; Schulzke JD
    Gut; 2004 Sep; 53(9):1295-302. PubMed ID: 15306588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of the major omentum-associated lymphoid tissue in Crohn disease].
    Schreiber S; Gehrckens A; Raedler A
    Zentralbl Chir; 1995; 120(2):135-44. PubMed ID: 7709665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sera from patients with Crohn's disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD-2 activity.
    Seksik P; Sokol H; Grondin V; Adrie C; Duboc H; Pigneur B; Thomas G; Beaugerie L; Trugnan G; Masliah J; Bachelet M
    Innate Immun; 2010 Dec; 16(6):381-90. PubMed ID: 20351135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide reduces bacterial superantigen-immune cell activation and consequent epithelial abnormalities.
    Rachlis A; Watson JL; Lu J; McKay DM
    J Leukoc Biol; 2002 Aug; 72(2):339-46. PubMed ID: 12149425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherent-invasive Escherichia coli and Crohn's disease.
    Barnich N; Darfeuille-Michaud A
    Curr Opin Gastroenterol; 2007 Jan; 23(1):16-20. PubMed ID: 17133079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.
    Caprilli R; Frieri G
    Dig Liver Dis; 2009 Feb; 41(2):166-8. PubMed ID: 19026604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease.
    Bertuccini L; Costanzo M; Iosi F; Tinari A; Terruzzi F; Stronati L; Aloi M; Cucchiara S; Superti F
    Dig Liver Dis; 2014 Jun; 46(6):496-504. PubMed ID: 24631031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.